Harbin Medisan Pharmaceutical Co Ltd (002900.SZ) stock: key figures, P/E, revenue and dividend
Health Care · Pharmaceuticals · China · ISIN CNE1000032V9
Harbin Medisan Pharmaceutical Co Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 1.13 bn CNY | 789.42 m CNY |
| Gross profit | 578.60 m CNY | 297.81 m CNY |
| Operating income | 62.01 m CNY | -275.26 m CNY |
| EBIT | 87.30 m CNY | -326.57 m CNY |
| Net income | 58.68 m CNY | -339.63 m CNY |
| Diluted EPS – continuing operations | 0.19 CNY | -1.07 CNY |
Full history since 2012, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Harbin Medisan Pharmaceutical Co Ltd
Harbin Medisan Pharmaceutical Co., Ltd. engages in the research, development, production, and sale chemical pharmaceutical preparations in China. The company offers various drugs for nervous system, cardiovascular system, systemic anti-infective, muscle and skeletal system, nutritional infusion, and body fluid balance infusion; and other products, including oxaliplatin for injection, calcium folinate for injection, hydroxylcamptothecine injection, tropisetron hydrochloride for injection, tropisetron hydrochloride and glucose injection, gabexate mesylate for injection, bismuth potassium citrate granules, pantoprazole sodium for injection, ambroxol hydrochloride and glucose injection, asarone for injection, paracetamol and tramadol hydrochloride tablets, rifamycin sodium for injection, lornoxicam for injection, vecuronium bromide for injection, and vitamin c for injection. It also provides manufacture, sale, and retail of pharmaceutical, drug development, technology investment consulting, logistics and transportation, medical devices, food, and cosmetics. Harbin Medisan Pharmaceutical Co., Ltd. was founded in 1996 and is headquartered in Harbin, China.
More stocks
- Wam Global Ltd (WGB.AX)
- Qingdao Kingking Applied Chemistry Co Ltd (002094.SZ)
- GYRE THERAPEUTICS, INC. (GYRE)
- Zhejiang Hengwei Battery Co. Ltd. (301222.SZ)
- Good Finance Securities Co Ltd (6021.TWO)
- Kofola CeskoSlovensko as (KOFOL.PR)
- Haypp Grp Ab (HAYPP.ST)
- Beijing Dataway Horizon Co. Ltd (301169.SZ)
- Unisound AI Technology Co Ltd (9678.HK)
- AMC Global Media Inc. (AMCX)
- Apex International Co Ltd (4927.TW)
- Solbar Ningbo Protein Technology Co., Ltd. (603231.SS)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.